Cancer stem cells: advances in knowledge and implications for cancer therapyXianjing Chu, Rongrong Zhou, Wentao Tian et al.|Signal Transduction and Targeted Therapy|2024Cited by 452
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical TrialsXianjing Chu, Rongrong Zhou, Wentao Tian et al.|Molecular Cancer|2023Cited by 194
The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-AnalysisXianjing Chu, Rongrong Zhou, Lishui Niu et al.|Frontiers in Immunology|2022Cited by 55
<p>Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma</p>Haiqing Peng, Rongrong Zhou|Cancer Management and Research|2019Cited by 33
Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basisWentao Tian, Rongrong Zhou, Xianjing Chu et al.|Journal of Translational Medicine|2023Cited by 20